|Assessment Status||Rapid Review Complete|
|Indication||Alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.|
|Rapid review commissioned||02/12/2015|
|Rapid review completed||15/12/2015|
|Rapid review outcome||Full Pharmacoeconomic Evaluation not Recommended|
The HSE has approved reimbursement following confidential price negotiations.